Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Suita
Clinical trial register · Japan

Clinical Trials in Suita, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Fukuoka 551 Nagoya 517 Sapporo 398 Tokyo 369 Osaka 348
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals19 Pfizer9 Merck Sharp & Dohme LLC7 National Cerebral and Cardiovascular Center, Japan4 Astellas Pharma Global Development, Inc.4
Site location
Fukuoka551 Nagoya517 Sapporo398 Tokyo369 Osaka348
All 926 locations
Target enrolment
to

Trials with a site in Suita

98 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Not yet open
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
92
Sapporo, Yokohama, Suita, Bunkyo-ku, Fukuoka, Maebashi, Okayama
2027-02-03
Recruiting
Novartis Pharmaceuticals
Phase 2
120
Yokohama, Suita, Hachiōji, Fukushima
2026-10-30
Recruiting
Merck Sharp & Dohme LLC
Phase 2
6
Izumi, Suita, Setagaya City
2026-09-17
Recruiting
Takeda
Phase 2
9
Nagoya, Maebashi, Tsu, Suita, Bunkyo-ku, Shinjuku-ku, Sumida-ku, Chūō
2026-07-14
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
Suita, Arakawa City, Hachiōji, Katsushika-ku, Musashino, Shinjuku, Fukuoka, Nagasaki
2026-06-30
Active, closed
AstraZeneca
Phase 2
326
Bunkyō City, Kurume-shi, Sapporo, Shinjuku-ku, Suita
2026-06-11
Recruiting
Pfizer
Phase 3
954
Suita, Chuo-ku, Shinjuku-ku
2026-06-10
Recruiting
Ipsen
Phase 3
350
Chiba, Hiroshima, Itabashi-ku, Yokohama, Ōmura, Kashihara, Niigata, Suita
2026-05-14
Recruiting
Genmab
Phase 2
160
Kashiwa, Yokohama, Suita, Kōtoku
2026-05-11
Recruiting
Novartis Pharmaceuticals
Phase 2
323
Suita, Chuo Ku, Chuo-ku, Shinjuku Ku
2026-05-07
Recruiting
TAMBE Japan Post-Marketing Surveillance
NCT07147569Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm
W.L.Gore & Associates
Observational
100
Minatoku, Nagoya, Osaka, Suita
2026-03-27
Recruiting
Bristol-Myers Squibb
Phase 3
325
Suita, Nankoku-shi, Osaka
2026-03-25
Recruiting
Novartis Pharmaceuticals
Observational
30
Kurume, Osaka, Suita, Bunkyo Ku
2026-03-23
Recruiting
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
NCT07118358Leadless Pacemaker, Bradycardia, AV Block, Cardiac Rhythm Disorder
Biotronik, Inc.
Not applicable
325
Kitakyushu, Suita
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Nagoya, Chiba, Kashiwa, Matsuyama, Yokohama, Kurashiki, Osaka, Suita
2026-03-13
Recruiting
TriClip Japan Post-Approval Study
NCT07509658Tricuspid Regurgitation
Abbott Medical Devices
Observational
250
Suita
2026-03-02
Recruiting
Acute Ischemic Stroke in Patients With Active Cancer
NCT07819526Acute Ischemic Stroke, Active Cancer
Osaka University
Observational
500
Suita
2026-03-01
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
614
Kashiwa, Matsuyama, Fukuoka, Kashihara-shi, Sakai, Suita, Bunkyo-ku, Koto
2026-02-17
Recruiting
Pfizer
Phase 1/2
224
Yokohama, Suita, Shinjuku-ku, Fukuoka, Yamagata
2026-02-10
Recruiting
Alnylam Pharmaceuticals
Phase 3
125
Bunkyo C, Kumamoto, Matsumoto-shi, Suita
2026-02-03
Recruiting
Alnylam Pharmaceuticals
Observational
2,000
Bunkyō City, Kumamoto, Kurume, Matsumoto, Sendai, Shinjuku, Suita, Tsukuba
2026-01-09
Active, closed
Novartis Pharmaceuticals
Phase 2
234
Matsudo, Takamatsu, Miyhazaki, Suita, Shinjuku Ku, Kyoto
2025-12-02
Recruiting
Pfizer
Phase 2/3
982
Nagoya, Chiba, Kashiwa, Kita-gun, Kawasaki, Yokohama, Suita, Nagaizumi-cho
2025-10-03
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Kanazawa, Kasugai, Kawasaki-shi, Okayama, Shōwaku, Suita, Toyoake-Shi, Urayasu
2025-09-30
Recruiting
Pfizer
Phase 3
1,000
Chiba, Matsuyama, Sapporo, Kobe, Kanazawa, Yokohama, Yokosuka, Suita
2025-09-28
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Nagoya-sh, Toyoake Shi, Asahikawa-shi, Suita, Suita-shi, Ōtsu, Chūōku, Fukuoka
2025-09-22
Recruiting
CSL Behring
Phase 3
200
Fukuoka, Suita, Fuchu-shi
2025-09-15
Recruiting
Sanofi
Phase 3
90
Nagoya, Tsuchiura, Kanazawa, Fujisawa, Suita, Iruma, Kofu, Fukuoka
2025-08-18
Recruiting
Pfizer
Phase 3
400
Chiba, Kashiwa, Matsuyama, Otashi, Isehara, Yokohama, Suita, Bunkyo-ku
2025-08-05
Recruiting
ELEVATE-HFpEF Clinical Study
NCT06678841Heart Failure With Preserved Ejection Fraction (HFpEF)
Medtronic Cardiac Rhythm and Heart Failure
Not applicable
700
Chiba, Kitakyushu, Suita
2025-07-09
Active, closed
Pfizer
Phase 1/2
74
Nagoya, Yokohama, Suita, Chuo-ku, Koto
2025-06-30
Active, closed
Arrowhead Pharmaceuticals
Phase 3
70
Kanazawa, Suita, Fukushima, Okayama, Saitama, Tokyo
2025-06-17
Recruiting
Aveir Leadless Pacemaker Japan PMS
NCT07106788Leadless Pacemaker
Abbott Medical Devices
Observational
304
Nagoya, Kitakyushu, Kawasaki, Sendai, Kurashiki, Hirakata, Osaka, Suita
2025-05-26
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Nagoya, Suita, Bunkyo, Mitaka, Fukuoka, Okayama
2025-05-12
Recruiting
Joseph Broderick, MD
Phase 3
350
Suita, Fukuoka, Gifu, Kagoshima, Kobe, Kyoto, Niigata, Osaka
2025-05-06
Active, closed
Novartis Pharmaceuticals
Phase 2
396
Suita, Chuo Ku, Chuo-ku, Shinjuku Ku
2025-03-26
Active, closed
Novartis Pharmaceuticals
Phase 2
126
Chiba, Sapporo, Kobe, Sendai, Suita, Bunkyo Ku, Shinjuku-ku, Fukuoka
2025-03-13
Recruiting
Masahisa Katsuno
Phase 2/3
68
Bunkyō City, Chiba, Sapporo, Shimotsuke, Suita
2025-02-28
By invitation
Inari Medical
Observational
100
Chuo, Ōta, Kawasaki, Suita, Asahikawa, Chiba, Daitō, Kanagawa
2025-02-17
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Sapporo, Nishinomiya, Hanamaki, Sendai, Suita, Higashi-Matsuyama, Koshigaya, Shinjuku Ku
2025-02-07
Active, closed
Pfizer
Phase 3
1,035
Nagoya, Otashi, Sapporo, Yokohama, Sakyo-ku, Sendai, Suita, Bunkyo-ku
2025-01-06
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
DrugRapcabtagene autoleucel
Novartis Pharmaceuticals
Phase 2
21
Sapporo, Yokohama, Sendai, Suita, Izumo, Bunkyo-ku, Shinjuku-ku, Fukuoka
2024-12-17
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Chiba, Chūōku, Kashiwa, Nagoya, Osaka, Sakai, Shizuoka, Suita
2024-12-12
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Sapporo, Himeji, Isehara, Sendai, Kawachi-Nagano, Sakai, Suita, Hamamatsu
2024-12-09
Active, closed
Kyowa Kirin Co., Ltd.
Phase 3
13
Ōbu, Suita, Waizumi, Fuchū, Yonago, Niigata, Okayama, Osaka
2024-12-01
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Narashino, Sapporo, Kobe, Yokohama, Okayama, Suita, Chiyoda City
2024-10-29
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Sapporo, Sendai, Suita, Bunkyo-ku, Fukuoka, Ishikawa, Kyoto
2024-10-29
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Chiba, Chūōku, Kashiwa, Nagoya, Osaka, Shizuoka, Suita, Tokyo
2024-10-18
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Chiba, Sapporo, Kobe, Yokohama, Sendai, Suita, Izumo, Bunkyo Ku
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Bunkyō City, Fukuoka, Mitaka, Nagoya, Okayama, Shinjuku-Ku, Suita
2024-09-03
Recruiting
Colorado Prevention Center
Phase 3
2,600
Sapporo, Isehara, Sagamihara, Kyoto, Sendai, Osaka, Suita, Ōta-ku
2024-08-20
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Sapporo, Himeji, Isehara, Sendai, Sakai, Suita, Hamamatsu, Bunkyō-Ku
2024-08-19
Active, closed
TAV-in-SAV in Japanese Patients
NCT06826027Valve-in-valve Procedures
Osaka University
Observational
180
Urayasu, Fukuoka, Kurume, Okayama, Osaka, Suita, Saga, Koshigaya
2024-08-07
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Chiba, Narita, Sapporo, Nishinomiya, Hanamaki, Sendai, Suita, Higashi-Matsuyama
2024-07-31
Active, closed
Cytokinetics
Phase 2/3
65
Kagoshima, Osaka, Sagamihara, Suita, Tokyo
2024-05-29
Active, closed
Osaka University
Phase 1
15
Suita
2024-05-24
Active, closed
Pfizer
Phase 2
333
Otashi, Sendai, Suita, Chuo-ku, Chiba, Hiroshima, Osaka
2024-01-09
Recruiting
BioMarin Pharmaceutical
Observational
400
Kumamoto, Suita, Yonago, Tokushima, Tokyo
2023-11-27
Recruiting
GramEye
Observational
10,000
Suita
2023-09-20
Recruiting
Chiesi Farmaceutici S.p.A.
Phase 2/3
16
Chikushino-shi, Sendai, Nishihara, Suita, Bunkyo-ku, Minato-ku, Shinjuku-ku, Asahikawa
2023-08-01
Recruiting
GramEye
Observational
18,000
Suita
2023-05-10
Active, closed
Bayer
Phase 3
985
Sapporo, Kanazawa, Yokohama, Suita, Bunkyo-ku, Kyoto
2023-04-03
Active, closed
Pfizer
Phase 3
624
Nagoya, Chiba, Kashiwa, Sapporo, Yokohama, Suita, Ina-machi, Bunkyo-ku
2023-03-03
Active, closed
TRISCEND JAPAN Study
NCT05760989Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases
Edwards Lifesciences
Not applicable
45
Kitakyushu-shi, Isehara-shi, Sendai, Osaka, Suita, Suita-shi, Shinjuku-Ku
2023-02-06
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Nagoya, Osaka, Suita, Kofu, Kumamoto
2023-02-02
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Narita, Matsuyama, Gifu, Kobe, Isehara, Suita, Itabashi-ku, Shinjuku Ku
2022-12-30
Active, closed
Amicus Therapeutics
Phase 3
14
Suita, Shizuoka
2022-10-31
Recruiting
Astellas Pharma Global Development, Inc.
Phase 1
398
Nagoya, Kashiwa, Yokohama, Sakai, Suita, Chuo-ku, Koto-ku
2022-06-07
Recruiting
Shionogi
Phase 1/2
282
Kashiwa, Suita, Chuo Ku
2022-05-30
Recruiting
Tadashi Watabe
Not applicable
200
Suita
2022-05-09
Active, closed
Joseph Broderick, MD
Phase 3
860
Suita, Fukuoka, Gifu, Kagoshima, Kobe, Kyoto, Morioka, Niigata
2021-12-03
Active, closed
Haihe Biopharma Co., Ltd.
Phase 2
93
Kurume, Suita, Chuo Ku, Minato-Ku, Shinjuku-Ku, Matsuyama, Nagoya, Niigata
2021-10-11
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Nagoya, Toyoake, Sapporo, Kobe, Kurashiki, Sakai, Suita, Shimotsuke
2021-10-06
Active, closed
Novartis Pharmaceuticals
Phase 3
208
Nagoya, Isehara, Suwa, Suita, Shinjuku Ku, Fukushima, Ishikawa, Kyoto
2021-07-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Nishinomiya, Kawasaki, Sagamihara, Suita, Hidaka, Shinjuku-ku, Chiba, Fukuoka
2021-06-18
Active, closed
Novartis Pharmaceuticals
Phase 3
1,140
Nagoya, Sapporo, Kobe, Yokohama, Kumamoto, Suita, Kitaadachi-gun, Bunkyo Ku
2021-06-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Toyoake, Kashiwa, Tōon, Sapporo, Yokohama, Kashihara, Sayama, Suita
2021-04-14
Active, closed
Novartis Pharmaceuticals
Phase 2
24
Nagoya, Kashiwa, Isehara, Yokohama, Kumamoto, Sendai, Osaka, Suita
2021-01-08
Active, closed
PharmaEssentia
Phase 3
174
Tōon, Sagamihara, Tsu, Miyazaki, Hirakata, Sayama, Suita, Izunokuni
2020-08-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Toyoake, Kashiwa, Tōon, Sapporo, Yokohama, Kashihara, Sayama, Suita
2020-02-27
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Nagoya, Kashiwa, Sapporo, Kobe, Yokohama, Suita, Koto, Fukuoka
2020-02-11
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Tsurumai-cho, Fukuoka, Kurume, Kita-gun, Nankoku, Matsumoto, Kashihara, Suita
2019-11-26
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Nagoya, Kashiwa, Kyoto, Suita, Tokyo
2018-12-12
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
507
Fukuoka, Akashi, Kawasaki, Yokohama, Suita, Utsunomiya, Chiba, Kashiwa
2018-11-28
Recruiting
REASSURE-NIRS Registry
NCT04864171Lipid-Rich Atherosclerosis of Coronary Artery
National Cerebral and Cardiovascular Center, Japan
Observational
2,000
Miyazaki, Suita
2018-10-09
Recruiting
Japanese Lead Extraction Registry
NCT04345627Arrhythmia, Cardiac
National Cerebral and Cardiovascular Center, Japan
Observational
5,000
Suita
2018-07-01
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsFolinic acid·Zolbetuximab·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Nagoya, Kashiwa, Matsuyama, Sapporo, Kobe, Suita, Hidaka, Kitaadachi-gun
2018-06-21
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Suita, Shizuoka, Okayama, Osaka
2017-08-23
Recruiting
Japanese Catheter Ablation Registry
NCT03729232Catheter Ablation, Cardiac Arrhythmias
National Cerebral and Cardiovascular Center, Japan
Observational
400,000
Suita
2017-07-01
Active, closed
Bolton Medical
Not applicable
110
Nagoya, Hiroshima, Sapporo, Kashihara, Niigata, Yufu, Joto-ku, Suita
2017-05-10
Active, closed
The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
NCT02979587Congenital Heart Disease, Tetrology of Fallot, RVOT Anomaly, Pulmonary Regurgitation
Medtronic Heart Valves
Not applicable
86
Suita
2017-01
Active, closed
National Cerebral and Cardiovascular Center, Japan
Observational
5,374
Suita
2016-10
Active, closed
Medtronic Cardiovascular
Not applicable
2,223
Kitakyushu, Sapporo, Tokyo, Kamakura, Sendai, Suita, Fuchū
2016-03
Active, closed
Edwards Lifesciences
Not applicable
1,000
Kitakyushu, Sendai, Suita, Shinjuku, tabashi City
2016-03
Active, closed
Bayer
Phase 3
24
Ōbu, Suita, Shinjuku-ku
2015-10-29
Active, closed
Medtronic
Observational
3,100
Mitaka-shi, Shinagawa, Suita, Yokohama
2015-07
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Nagoya, Sapporo, Isehara, Suita, Bunkyo Ku, Fukuoka, Osaka
2015-03-05
Recruiting
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Observational
120
Suita, Kodaira
2014-01
Rows per page Showing 1–98 of 98
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/suita

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 98 of those studies with a site in Suita.

How many clinical trials are recruiting in Suita?

46 of the 98 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 49 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Suita), 98 studies
PhaseStudiesRecruitingShare
Phase 3401540.8%
Phase 219619.4%
Observational171317.3%
Not applicable838.2%
Phase 2/3656.1%
Phase 1424.1%
Phase 1/2323.1%
Phase 4101%

Most active sponsors

Lead sponsors with the most studies (Suita)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals193
Pfizer95
Merck Sharp & Dohme LLC72
Astellas Pharma Global Development, Inc.42
National Cerebral and Cardiovascular Center, Japan43
Alnylam Pharmaceuticals32
Bristol-Myers Squibb33
Osaka University31
Abbott Medical Devices22
Bayer20
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.